Aspen Aerogels (NYSE: ASPN) reported Q3 EPS of ($0.19), $0.11 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $60.8 million versus the consensus estimate of $50.8 million.

GUIDANCE:

Aspen Aerogels sees FY2023 EPS of ($0.90)-($0.76), versus the consensus of ($1.04). Aspen Aerogels sees FY2023 revenue of $225 million, versus the consensus of $216 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.